NORTHERN TRUST CORP - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 25 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q3 2020$93,000
-44.3%
842,203
+20.3%
0.00%
Q2 2020$167,000
+122.7%
700,163
+114.4%
0.00%
Q2 2019$75,000
-39.0%
326,583
-6.8%
0.00%
Q1 2019$123,000
-71.6%
350,568
-0.4%
0.00%
Q4 2018$433,000
-34.4%
351,842
-0.4%
0.00%
Q3 2018$660,000
+358.3%
353,334
+450.2%
0.00%
Q2 2018$144,00064,2190.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q3 2019
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,254,080$2,325,0000.02%
jvl associates llc 58,500$11,0000.01%
RETIREMENT INCOME SOLUTIONS, INC 32,060$6,000,0000.00%
ISTHMUS PARTNERS, LLC 30,600$6,0000.00%
UBS Group AG 50,247$10,0000.00%
BNP PARIBAS FINANCIAL MARKETS 225$43,0000.00%
OSAIC HOLDINGS, INC. 6,000$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TORONTO DOMINION BANK 20$00.00%
MORGAN STANLEY 100$00.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders